Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

47.000
-0.500-1.05%
Volume:33.56M
Turnover:1.57B
Market Cap:195.33B
PE:34.62
High:47.500
Open:47.500
Low:46.160
Close:47.500
52wk High:54.450
52wk Low:28.480
Shares:4.16B
HK Float Shares:4.16B
Volume Ratio:1.23
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.358
ROE:11.38%
ROA:7.60%
PB:3.47
PE(LYR):34.62
PS:7.07

Loading ...

Wuxi Biologics (Cayman) Stock Slips 2.7% in Hong Kong

Dow Jones
·
Sep 10

Movement Alert|WUXI BIO Falls 3.07% in Regular Trading, Trading at 47.44 HKD

Market Focus
·
Sep 10

WuXi Biologics Issues 1.20 Million New Shares; 39.82 Million Shares Await Cancellation

Bulletin Express
·
Sep 09

WuXi Biologics Files HKEX Next-Day Disclosure, Share Capital Rises by 1.2 Million Shares

Reuters
·
Sep 09

Transcenta Licenses HiCB Bioprocessing Technology to WuXi Biologics for RMB 10 Million Upfront

Reuters
·
Sep 09

Transcenta Holding - to Receive RMB 10 Mln Upfront Payment and Milestone Payments

THOMSON REUTERS
·
Sep 09

Transcenta Holding - Grants WuXi Biologics Non-Exclusive License to Hicb Platform and Excelpro Cell Culture Media

THOMSON REUTERS
·
Sep 09

Wuxi Biologics (Cayman) Stock Climbs 1.7% in Hong Kong

Dow Jones
·
Sep 08

WuXi Biologics Files HKEX Next-Day Disclosure Return, Issues 1,804,090 New Shares

Reuters
·
Sep 07

Wuxi Biologics (Cayman) Stock Slides 1.4% in Hong Kong

Dow Jones
·
Sep 07

WuXi Bio Issues 3.2 Million Shares Following Option Exercise

Stock News
·
Sep 04

Wall Street Cues, Easing Bond Yields Boost Asian Stock Markets

MT Newswires Live
·
Sep 04

Movement Alert|WUXI BIO Falls 3.12% in Regular Trading, Post-Earnings Profit-Taking and CXO Sector Pullback Weigh on Shares

Market Focus
·
Sep 04

WuXi Biologics Files HKEX Next-Day Disclosure Return, Share Capital Rises by 2,423,900 Shares

Reuters
·
Sep 03

Wuxi Biologics (Cayman) Stock Advances 3.0% in Hong Kong

Dow Jones
·
Sep 03

Movement Alert|WUXI BIO Rises 3.27% in Regular Trading, Large-Scale Buyback of Over HK$1.27 Billion Boosts Market Confidence

Market Focus
·
Sep 03

WuXi Biologics Files HKEX Next-Day Disclosure Return Reporting 1,527,500 New Shares Issued Via Option Exercises

Reuters
·
Sep 02

Wuxi Biologics (Cayman) Stock Slips 3.6% in Hong Kong

Dow Jones
·
Aug 31

WuXi Biologics' Stronger Project Backlog Could Underpin Revenue Visibility

Dow Jones
·
Aug 31

Movement Alert|WUXI BIO Falls 4.4% in Regular Trading, Profit-Taking Extends After Strong Interim Results

Market Focus
·
Aug 31